Redwood Biosciences is involved in developing antibody-drug conjugates (ADCs) and optimized site-specific protein-modification technologies for bioconjugates, focusing on improving drug delivery and efficacy in cancer treatments
Redwood Biosciences is involved in developing antibody-drug conjugates (ADCs) and optimized site-specific protein-modification technologies for bioconjugates, focusing on improving drug delivery and efficacy in cancer treatments.